Skip to main content
. 2022 Aug 29;9(6):e200021. doi: 10.1212/NXI.0000000000200021

Figure 3. Marginal Effects of Death vs None by DMT Type Relative to Glatiramer Acetate.

Figure 3

Adjusted for age, sex, MS phenotype, and disability. Full lines include suspected + confirmed COVID-19, while dashed lines are confirmed COVID-19 only. COVID-19 = coronavirus disease 2019; DMT = disease-modifying therapy; MS = multiple sclerosis; * = p < 0.05.